Inhibition of retrovirus RNA-dependent DNA polymerase by novobiocin and nalidixic acid.
Inhibitors of bacterial DNA gyrase and eukaryotic DNA topoisomerase (novobiocin and nalidixic acid) were investigated with respect to their effect on the activity of RNA-dependent DNA polymerases from murine and avian retroviruses. Purified RNA-dependent DNA polymerase from AKR virus was inhibited more than 90% by 0.3 mg/ml and almost completely by 1 mg/ml of the drugs when poly(A) X oligo(dT)12-18 was used as a template-primer. In contrast to the enzyme from AKR virus, purified enzyme from avian myeloblastosis virus was less sensitive, i.e. nearly 50% activity remained even in the presence of 1 mg/ml of the drugs with the same template-primer. RNA-dependent DNA polymerase activity in AKR virus particles was inhibited, but was resistant to low concentrations of the drugs. The inhibition was not due to specific interaction between drugs and the template-primer or labelled precursor, since RNA-dependent DNA polymerase was inhibited by the drugs with activated calf thymus DNA or poly(C) X oligo(dG)12-18 as the template. Endogenous DNA synthesis by AKR virus particles was inhibited by novobiocin to the same extent.
D000406:AKR murine leukemia virus / Q000187:drug effects / Q000201:enzymology; D000818:Animals; D001358:Avian Sarcoma Viruses / Q000187:drug effects / Q000201:enzymology; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D051379:Mice; D009268:Nalidixic Acid / Q000494:pharmacology*; D009675:Novobiocin / Q000494:pharmacology*; D012190:Retroviridae / Q000187:drug effects / Q000201:enzymology*; D014771:Virion / Q000187:drug effects / Q000201:enzymology
D009675:Novobiocin; D009268:Nalidixic Acid; D012321:DNA-Directed RNA Polymerases